HUP0204547A3 - Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms - Google Patents
Use of indoloquinoxaline derivatives for preparing a drug for treatment of msInfo
- Publication number
- HUP0204547A3 HUP0204547A3 HU0204547A HUP0204547A HUP0204547A3 HU P0204547 A3 HUP0204547 A3 HU P0204547A3 HU 0204547 A HU0204547 A HU 0204547A HU P0204547 A HUP0204547 A HU P0204547A HU P0204547 A3 HUP0204547 A3 HU P0204547A3
- Authority
- HU
- Hungary
- Prior art keywords
- drug
- preparing
- treatment
- indoloquinoxaline
- derivatives
- Prior art date
Links
- NXOVZLREWXNIDP-UHFFFAOYSA-N 7h-pyrazino[2,3-c]carbazole Chemical class N1=CC=NC2=C3C4=CC=CC=C4NC3=CC=C21 NXOVZLREWXNIDP-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000537A SE516067C2 (sv) | 2000-02-18 | 2000-02-18 | Användning av en förening för framställning av ett läkemedel |
PCT/SE2001/000326 WO2001060371A1 (en) | 2000-02-18 | 2001-02-16 | Use of a compound for preparing a drug |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0204547A2 HUP0204547A2 (hu) | 2003-04-28 |
HUP0204547A3 true HUP0204547A3 (en) | 2006-01-30 |
Family
ID=20278504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0204547A HUP0204547A3 (en) | 2000-02-18 | 2001-02-16 | Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1261344B1 (hu) |
JP (1) | JP2003522792A (hu) |
CN (1) | CN1192777C (hu) |
AT (1) | ATE269083T1 (hu) |
AU (2) | AU2001236266B2 (hu) |
CA (1) | CA2400236C (hu) |
DE (1) | DE60103857T2 (hu) |
ES (1) | ES2222981T3 (hu) |
HU (1) | HUP0204547A3 (hu) |
NO (1) | NO323783B1 (hu) |
RU (1) | RU2266117C2 (hu) |
SE (1) | SE516067C2 (hu) |
WO (1) | WO2001060371A1 (hu) |
ZA (1) | ZA200206733B (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE527639C2 (sv) | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
EP2128160B1 (en) | 2008-04-30 | 2010-07-14 | Universität Duisburg-Essen | Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8600260D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Substituerade indolokinoxaliner |
-
2000
- 2000-02-18 SE SE0000537A patent/SE516067C2/sv not_active IP Right Cessation
-
2001
- 2001-02-16 AU AU2001236266A patent/AU2001236266B2/en not_active Ceased
- 2001-02-16 AU AU3626601A patent/AU3626601A/xx active Pending
- 2001-02-16 CA CA002400236A patent/CA2400236C/en not_active Expired - Fee Related
- 2001-02-16 JP JP2001559467A patent/JP2003522792A/ja active Pending
- 2001-02-16 ES ES01908522T patent/ES2222981T3/es not_active Expired - Lifetime
- 2001-02-16 HU HU0204547A patent/HUP0204547A3/hu unknown
- 2001-02-16 RU RU2002124771/15A patent/RU2266117C2/ru active
- 2001-02-16 DE DE60103857T patent/DE60103857T2/de not_active Expired - Fee Related
- 2001-02-16 EP EP01908522A patent/EP1261344B1/en not_active Expired - Lifetime
- 2001-02-16 WO PCT/SE2001/000326 patent/WO2001060371A1/en active IP Right Grant
- 2001-02-16 AT AT01908522T patent/ATE269083T1/de not_active IP Right Cessation
- 2001-02-16 CN CNB018052045A patent/CN1192777C/zh not_active Expired - Fee Related
-
2002
- 2002-08-16 NO NO20023892A patent/NO323783B1/no not_active IP Right Cessation
- 2002-08-22 ZA ZA200206733A patent/ZA200206733B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0204547A2 (hu) | 2003-04-28 |
CN1404393A (zh) | 2003-03-19 |
CA2400236C (en) | 2009-09-22 |
CN1192777C (zh) | 2005-03-16 |
NO20023892D0 (no) | 2002-08-16 |
NO20023892L (no) | 2002-08-16 |
RU2002124771A (ru) | 2004-03-10 |
JP2003522792A (ja) | 2003-07-29 |
SE0000537L (sv) | 2001-08-19 |
ES2222981T3 (es) | 2005-02-16 |
ZA200206733B (en) | 2003-08-22 |
DE60103857D1 (de) | 2004-07-22 |
EP1261344B1 (en) | 2004-06-16 |
CA2400236A1 (en) | 2001-08-23 |
DE60103857T2 (de) | 2005-07-14 |
WO2001060371A1 (en) | 2001-08-23 |
RU2266117C2 (ru) | 2005-12-20 |
SE0000537D0 (sv) | 2000-02-18 |
AU3626601A (en) | 2001-08-27 |
SE516067C2 (sv) | 2001-11-12 |
ATE269083T1 (de) | 2004-07-15 |
NO323783B1 (no) | 2007-07-09 |
EP1261344A1 (en) | 2002-12-04 |
AU2001236266B2 (en) | 2005-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1158992T1 (en) | Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications | |
HUP0203803A3 (en) | Pyridopyrimidinone derivatives for treatment of neurodegenerative disease | |
EP1311261A4 (en) | MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES | |
GB0013378D0 (en) | Use of therapeutic benzamide derivatives | |
IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
GB0013383D0 (en) | Therapeutic benzamide derivatives | |
AU6401101A (en) | Use of biguanide derivatives for making a medicine having a wound healing effect | |
GB0013346D0 (en) | Therapeutic benzamide derivatives | |
HRP20020893A2 (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
IL144590A0 (en) | A process for the preparation of epothilone derivatives | |
IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
IL148166A0 (en) | Drug for treating fractures | |
IL150290A (en) | Use of mirtazapine for preparation of a medicament for the treatment of sleep disorders | |
IL147496A0 (en) | Preparation of a therapeutic composition | |
IL156647A0 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof | |
IL150837A (en) | Use of fsh for preparing a medicament for treating infertility | |
IL155431A0 (en) | Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders | |
HUP0204547A3 (en) | Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms | |
HUP0203468A3 (en) | Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof | |
HK1059895A1 (en) | Use of pyridoindolone derivatives for preparing anticancer medicines | |
HUP0600063A2 (en) | Novel therapeutic use of a thienylcyclohexylamine derivative | |
EP1307180A4 (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | |
PL354872A1 (en) | Oral dosage form comprising a salt of morphine or a morphine derivative | |
AU2001236266A1 (en) | Use of a compound for preparing a drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |